(Q81816352)
Statements
Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma (English)
G G Wulf
J Hasenkamp
W Jung
B Chapuy
L Truemper
1 August 2005